Children victims of drug error
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Thirteen children suffering from leukaemia were given the wrong dose of a chemotherapy drug at Birmingham Children's Hospital, it was revealed yesterday.
At least one family is planning legal action after a batch of the drug, Vincristine, was incorrectly labelled and supplied to the hospital in the summer.
A double dose was given to each child on one occasion between 22 and 25 August, the hospital said.
As a result most of the children had unpleasant side-effects, including stomach pain, constipation and tingling, for a number of days. One child had to be admitted to hospital and at least two others suffered "further significant loss of hair" while recovering from previous chemotherpay. None had significant long-term effects, a hospital statement said.
A member of staff in the hospital pharmacy noticed the dose was unusual. The firm which supplied it was alerted, it nitiated an inquiry and introduced additional safety checks
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments